These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3265052)

  • 1. Biological significance of the antibody response to HIV antigens expressed on the cell surface.
    Goudsmit J; Ljunggren K; Smit L; Jondal M; Fenyö EM
    Arch Virol; 1988; 103(3-4):189-206. PubMed ID: 3265052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages.
    Ljunggren K; Böttiger B; Biberfeld G; Karlson A; Fenyö EM; Jondal M
    J Immunol; 1987 Oct; 139(7):2263-7. PubMed ID: 3498755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC.
    Lyerly HK; Reed DL; Matthews TJ; Langlois AJ; Ahearne PA; Petteway SR; Weinhold KJ
    AIDS Res Hum Retroviruses; 1987; 3(4):409-22. PubMed ID: 2833917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-dependent cellular cytotoxicity (ADCC)-mediated destruction of human immunodeficiency virus (HIV)-coated CD4+ T lymphocytes by acquired immunodeficiency syndrome (AIDS) effector cells.
    Katz JD; Nishanian P; Mitsuyasu R; Bonavida B
    J Clin Immunol; 1988 Nov; 8(6):453-8. PubMed ID: 2975670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic specificity of antibody-dependent cell-mediated cytotoxicity directed against human immunodeficiency virus in antibody-positive sera.
    Koup RA; Sullivan JL; Levine PH; Brewster F; Mahr A; Mazzara G; McKenzie S; Panicali D
    J Virol; 1989 Feb; 63(2):584-90. PubMed ID: 2536094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection.
    Sawyer LA; Katzenstein DA; Hendry RM; Boone EJ; Vujcic LK; Williams CC; Zeger SL; Saah AJ; Rinaldo CR; Phair JP
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):341-56. PubMed ID: 1971182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
    J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction in chimpanzees of antibodies inhibiting receptor-mediated cell fusion by HIV glycoprotein.
    Goudsmit J; Smit L; Klaver B; Asher DM; Wolff A; Gibbs CJ; Gajdusek DC
    Viral Immunol; 1987-1988; 1(3):225-40. PubMed ID: 3509947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broadly reactive antibody-dependent cellular cytotoxic response to HIV-1 envelope glycoproteins precedes broad neutralizing response in human infection.
    Koup RA; Pikora CA; Mazzara G; Panicali D; Sullivan JL
    Viral Immunol; 1991; 4(4):215-23. PubMed ID: 1726398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and effector-cell antibody-dependent cellular cytotoxicity (ADCC) activity remains high during human immunodeficiency virus (HIV) disease progression.
    Ojo-Amaize E; Nishanian PG; Heitjan DF; Rezai A; Esmail I; Korns E; Detels R; Fahey J; Giorgi JV
    J Clin Immunol; 1989 Nov; 9(6):454-61. PubMed ID: 2576558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-dependent cellular cytotoxicity detects type- and strain-specific antigens among human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus SIVmac isolates.
    Ljunggren K; Biberfeld G; Jondal M; Fenyö EM
    J Virol; 1989 Aug; 63(8):3376-81. PubMed ID: 2746734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of antibodies which mediate human immunodeficiency virus-specific cellular cytotoxicity (ADCC) in vitro.
    Ljunggren K; Fenyö EM; Biberfeld G; Jondal M
    J Immunol Methods; 1987 Nov; 104(1-2):7-14. PubMed ID: 2445825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the serologic profile of children with human immunodeficiency virus infection: correlation with clinical status.
    Kamani N; Krilov LR; Wittek AE; Hendry RM
    Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 1):233-42. PubMed ID: 2791340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humans.
    Williams KL; Cortez V; Dingens AS; Gach JS; Rainwater S; Weis JF; Chen X; Spearman P; Forthal DN; Overbaugh J
    EBioMedicine; 2015 Oct; 2(10):1464-77. PubMed ID: 26629541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.
    Tyler DS; Stanley SD; Nastala CA; Austin AA; Bartlett JA; Stine KC; Lyerly HK; Bolognesi DP; Weinhold KJ
    J Immunol; 1990 May; 144(9):3375-84. PubMed ID: 2329275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement-dependent cytotoxicity of antibodies reactive with HIV-induced cell surface antigens in HIV-carrying haemophiliacs.
    Tóth FD; Kiss J; Szabó B; Füst G; Ujhelyi E; Hollán SR; Váczi L
    Acta Virol; 1989 Dec; 33(6):521-6. PubMed ID: 2576594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunodominant B-cell clones responsive to an HIV-1 neutralization and cell fusion inhibition epitope in chimpanzee-to-chimpanzee passages of HTLV-IIIB and LAV-1.
    Goudsmit J; Bakker M; Smit L
    Res Virol; 1989; 140(5):405-18. PubMed ID: 2479965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional activity of an HIV-1 neutralizing IgG human monoclonal antibody: ADCC and complement-mediated lysis.
    Posner MR; Elboim HS; Cannon T; Cavacini L; Hideshima T
    AIDS Res Hum Retroviruses; 1992 May; 8(5):553-8. PubMed ID: 1381201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of HIV-specific antibody-dependent cellular cytotoxicity in HIV prevention and the influence of the HIV-1 Vpu protein.
    Kramski M; Stratov I; Kent SJ
    AIDS; 2015 Jan; 29(2):137-44. PubMed ID: 25396265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing antibodies in relation to antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus type I.
    Böttiger B; Ljunggren K; Karlsson A; Krohn K; Fenyö EM; Jondal M; Biberfeld G
    Clin Exp Immunol; 1988 Sep; 73(3):339-42. PubMed ID: 3208445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.